Identification

Description


Formule moléculaire brute : C3H6N2S

Principaux synonymes

Noms français :

  • 1,3-ETHYLENE-2-THIOUREA
  • 1,3-ETHYLENETHIOUREA
  • 2-IMIDAZOLIDENE-2-THIOL
  • 2-IMIDAZOLIDINETHIONE
  • 2-IMIDAZOLINE-2-THIOL
  • 2-MERCAPTO-2-IMIDAZOLINE
  • 2-MERCAPTOIMIDAZOLINE
  • 2-THIOL-DIHYDROGLYOXALINE
  • 2H-IMIDAZOLE-2-THIONE, TETRAHYDRO
  • 4,5-DIHYDRO-2-MERCAPTOIMIDAZOLE
  • 4,5-DIHYDROIMIDAZOLE-2(3H)-THIONE
  • Ethylene thiourea
  • ETHYLENETHIOUREA
  • Ethylène thiourée
  • Ethylènethiourée
  • IMADAZOLINE-2-THIOL
  • IMIDAZOLIDINETHIONE
  • IMIDAZOLINE-2(3H)-THIONE
  • MERCAPTOIMIDAZOLINE
  • N,N'-(1,2-ETHANEDIYL)THIOUREA
  • N,N'-ETHYLENE-THIOUREA
  • N,N'-ETHYLENETHIOUREA
  • TETRAHYDRO-2H-IMIDAZOLE-2-THIONE
  • Éthylènethiourée

Noms anglais :

  • Ethylene thiourea
Utilisation et sources d'émission

Fongicide, agent d'anti-oxydant

Références

  • ▲1.  International Program on Chemical Safety, Thiourea. Concise International Chemical Assessment . Genève : World Health Organization. (2003). CICAD 49.
  • ▲2.  McCleskey, P.E. et Swerlick, R.A., «Clinical review : thioureas and allergic contact dermatitis.» Cutis. Vol. 68, no. 6, p. 387-396. (2001).
  • ▲3.  Azenha, A. et al., «Thiourea contact sensitivity in Portugal.» In: Current topics in contact dermatitis. , p. 294-297. New-York : Spring Verlag. (1989). [MO-013906]
  • ▲4.  Bruze, M. et Fregert, S., «Allergic contact dermatitis from ethylene thiourea.» Contact Dermatitis. Vol. 9, p. 208-212. (1983).
  • ▲5.  Kanerva, L., Estlander, T. et Jolanki, R., «Occupational allergic contact dermatitis caused by thiourea compounds.» Contact Dermatitis. Vol. 31, p. 242-248. (1994).
  • ▲6.  Meding, B. et al., «Allergic contact dermatitis from diphenylthiourea in Vulkan heat retainers.» Contact Dermatitis. Vol. 22, p. 8-12. (1990).
  • ▲7.  IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Overall evaluations of carcinogenicity : an updating of IARC monographs volumes 1-42. IARC monographs on the evaluation of carcinogenic risks to humans, Supplement 7. Lyon : International Agency for Research on Cancer. (1987).   https://monographs.iarc.fr/wp-content/uploads/2018/06/Suppl7.pdf
    http://monographs.iarc.fr/
  • ▲8.  IARC Working Group on the Evaluation Evaluation of Carcinogenic Risks to Humans, Some thyrotropic agents. IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 79. Lyon : Internationall Agency for Research on Cancer. (2001).   https://monographs.iarc.fr/wp-content/uploads/2018/06/mono79.pdf
  • ▲9.  IARC Working Group on the Evaluation of Carcinogenic Risks of Chemical to Man, Some anti-thyroid and related substances, nitrofurans and industrial chemicals. IARC monographs on the evaluation of carcinogenic risks of chemical to man, Vol. 7. Lyon : International Agency for Research on Cancer. (1974).   https://monographs.iarc.fr/wp-content/uploads/2018/06/mono7.pdf
    http://www.iarc.fr
  • ▲10.  Report on Carcinogens, 15th edition. Research Triangle Park, NC : U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program. (2021).   https://ntp.niehs.nih.gov/pubhealth/roc/index-1.html
  • ▲11.  Règlement sur la santé et la sécurité du travail [S-2.1, r. 13]. Québec : Éditeur officiel du Québec. [RJ-510071]   http://legisquebec.gouv.qc.ca/fr/ShowDoc/cr/S-2.1,%20r.%2013

La cote entre [ ] provient de la banque Information SST du Centre de documentation de la CNESST.